NIH-funded research R01 grant

How prescription stimulants may affect overdose risk

Official title: Impact of prescription stimulants on the drug overdose epidemic

Funded at Mclean Hospital · NIH-11324579 · Data updated 2026-11-12

Researchers are using adults' medical and prescription records to see whether getting stimulant medications is linked to a higher or lower chance of later overdoses.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMclean Hospital
NIH-funded
Lab location1 site (Belmont, United States)
Project startMay 1, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$714,786
NIH project number5R01DA058315-04
Project IDNIH-11324579 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21 and older who have received prescription stimulants or who have a history of stimulant or other substance use are the main groups reflected in the records studied.

Less likely to help

People under 21, or those with no exposure to prescription or illicit stimulants, are unlikely to be included or to directly benefit from this project.

What this research studies

You would not be asked to visit a clinic; the team will use large, real-world health databases and prescription records to follow adults who received stimulant medications. They will link prescription histories with emergency department, toxicology, and mortality records to look for patterns of transition to illicit stimulants and overdoses involving fentanyl. The researchers will compare people prescribed stimulants to similar people who were not, to separate medication effects from other risks. This work is designed to clarify whether prescriptions are associated with increased harm or possible benefits in routine care.

Why it matters

Potential benefit: If links are identified, the results could help doctors prescribe and monitor stimulants more safely to reduce overdose risk.

How similar studies have gone: Some clinical trials have shown stimulants can aid short-term abstinence for people with substance use disorders, but using linked real-world records to connect prescriptions to overdose outcomes is relatively new.

Where this research is happening

  • Mclean Hospital
    Belmont, United States
    Active

Researchers

  • Principal investigator: De Nadai, Alessandro Stevens — Mclean Hospital
  • Study coordinator: De Nadai, Alessandro Stevens

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.